Vimarsana
Biggest News Aggregation in the World

Page 12 - Global External News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global External. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global External Today - Breaking & Trending Today

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces the schedule of publication and presentation of its 2022 Half-Year Financial Results - Vimarsana News

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces the schedule of publication and presentation of its 2022 Half-Year Financial Results

Investegate announcements from INVENTIVA, Inventiva announces the schedule of publication and presentation of its 2022 Half-Year Financial Results

Sierra Metals Inc.: Sierra Metals Reports Q2 2022 Consolidated Financial Results and Provides Revised Production, EBITDA, Cost & Capital Expenditure Guidance For 2022 - Vimarsana News

Sierra Metals Inc.: Sierra Metals Reports Q2 2022 Consolidated Financial Results and Provides Revised Production, EBITDA, Cost & Capital Expenditure Guidance For 2022

Conference Call August 12, 2022 at 11:00 AM (EDT) (All figures reported in USD) Revised production, EBITDA and Cost guidance due to lower than expected performance at Bolivar and Cusi, offset

Orbis and Alcon to Kick Off Two-Week Training for Caribbean Eye Care Teams to Help Fight Avoidable Blindness in Local Communities - Vimarsana News

Orbis and Alcon to Kick Off Two-Week Training for Caribbean Eye Care Teams to Help Fight Avoidable Blindness in Local Communities

/PRNewswire/ -- On Monday, August 8, Orbis International, with generous support from Alcon, the global leader in eye care, will kick off its first in-person...

Orbis and Alcon to Kick Off Two-Week Training for Caribbean Eye Care Teams to Help Fight Avoidable Blindness in Local Communities - Vimarsana News

Orbis and Alcon to Kick Off Two-Week Training for Caribbean Eye Care Teams to Help Fight Avoidable Blindness in Local Communities

/PRNewswire/ -- On Monday, August 8, Orbis International, with generous support from Alcon, the global leader in eye care, will kick off its first in-person...

Inventiva announces the screening of the first patient in LEGEND, a Phase IIa combination trial with lanifibranor and empagliflozin in patients with NASH and T2D - Vimarsana News

Inventiva announces the screening of the first patient in LEGEND, a Phase IIa combination trial with lanifibranor and empagliflozin in patients with NASH and T2D

The Phase IIa Proof-of-Concept study is designed to assess the safety and efficacy of lanifibranor in combination with the SGLT2 inhibitor empagliflozin for the treatment of patients with... | July 7, 2022